FI875102L - Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi - Google Patents

Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi Download PDF

Info

Publication number
FI875102L
FI875102L FI875102A FI875102A FI875102L FI 875102 L FI875102 L FI 875102L FI 875102 A FI875102 A FI 875102A FI 875102 A FI875102 A FI 875102A FI 875102 L FI875102 L FI 875102L
Authority
FI
Finland
Prior art keywords
preparation
imidazole derivative
pharmaceutical substance
analogous method
derivative useful
Prior art date
Application number
FI875102A
Other languages
English (en)
Swedish (sv)
Other versions
FI91754B (fi
FI91754C (fi
FI875102A0 (fi
Inventor
Yasushi Honma
Hajime Tamaki
Tetsuo Magaribuchi
Mine Takido
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of FI875102A0 publication Critical patent/FI875102A0/fi
Publication of FI875102L publication Critical patent/FI875102L/fi
Publication of FI91754B publication Critical patent/FI91754B/fi
Application granted granted Critical
Publication of FI91754C publication Critical patent/FI91754C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI875102A 1986-12-02 1987-11-18 Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi FI91754C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP28751286 1986-12-02
JP28751286 1986-12-02
JP8047587 1987-03-31
JP8047587 1987-03-31
JP21581387 1987-08-28
JP21581387 1987-08-28

Publications (4)

Publication Number Publication Date
FI875102A0 FI875102A0 (fi) 1987-11-18
FI875102L true FI875102L (fi) 1988-06-03
FI91754B FI91754B (fi) 1994-04-29
FI91754C FI91754C (fi) 1994-08-10

Family

ID=27303307

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875102A FI91754C (fi) 1986-12-02 1987-11-18 Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi

Country Status (15)

Country Link
US (3) US5002945A (fi)
EP (1) EP0270091B1 (fi)
JP (1) JPH064623B2 (fi)
KR (1) KR930004843B1 (fi)
CN (1) CN1020902C (fi)
AU (1) AU597446B2 (fi)
DE (1) DE3782621T2 (fi)
DK (1) DK631587A (fi)
ES (1) ES2044901T3 (fi)
FI (1) FI91754C (fi)
FR (1) FR2607502B1 (fi)
GR (1) GR3006257T3 (fi)
HU (2) HU204812B (fi)
IL (1) IL84554A (fi)
TW (1) TW203048B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols
JP2614756B2 (ja) * 1988-08-10 1997-05-28 日本ケミファ株式会社 イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
MY106533A (en) * 1990-02-20 1995-06-30 Sumitomo Chemical Co A 4-tert.-butyl imidazole derivative and its production and use.
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
CA2036147A1 (en) * 1990-06-29 1991-12-30 Hiroki Tomioka A 1-pyridylimidazole derivative and its production and use
MY110439A (en) * 1991-02-07 1998-05-30 Ishihara Sangyo Kaisha N-phenylcarbamate compound, process for preparing the same and biocidal composition for control of harmful organisms
AU644297B2 (en) * 1991-06-28 1993-12-02 Sumitomo Chemical Company, Limited A 1-pyridylimidazole derivative and its production and use
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
DE19541146A1 (de) * 1995-10-25 1997-04-30 Schering Ag Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
CA2566094A1 (en) * 2004-05-26 2005-12-08 Eisai R & D Management Co., Ltd. Cinnamide compound
EP1810677A1 (en) * 2004-10-08 2007-07-25 Takeda Pharmaceutical Company Limited Receptor function regulating agent
TWI370130B (en) 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
CL2008000582A1 (es) 2007-02-28 2008-06-27 Eisai R&D Man Co Ltd Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis.
CA2694401C (en) 2007-08-31 2012-12-04 Eisai R&D Management Co., Ltd. Polycyclic compound

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (fi) * 1968-10-21 1971-06-03
IN148930B (fi) * 1977-09-19 1981-07-25 Hoffmann La Roche
EP0004648B1 (de) * 1978-04-11 1982-08-25 Ciba-Geigy Ag Neue Mercaptoimidazolderivate, Verfahren zu deren Herstellung, Mercaptoimidazolderivate zur Behandlung entzündlicher Erkrankungen und diese enthaltende pharmazeutische Präparate
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
DE3369845D1 (en) * 1982-12-20 1987-04-02 Merck & Co Inc 5-(amino or substituted amino) imidazoles
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
FI833794A0 (fi) * 1983-10-18 1983-10-18 Farmos Oy Substituerade 2-merkapto-imidazoler
GB8417171D0 (en) * 1984-07-05 1984-08-08 Beecham Group Plc Compounds
EP0174717B1 (en) * 1984-07-06 1992-01-22 FISONS plc Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
US4600430A (en) * 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols
US4591377A (en) * 1985-09-10 1986-05-27 Stauffer Chemical Company Herbicidal esters of 2-bromo-4-methylimidazole-5-carboxylic acid
JP2581556B2 (ja) * 1986-05-06 1997-02-12 メレルダウファーマスーティカルズ インコーポレーテッド 新規なドパミンベ−タヒドロキシラ−ゼ抑制剤
JPH0674273B2 (ja) * 1986-06-19 1994-09-21 日産化学工業株式会社 イミダゾ−ルスルホンアミド誘導体、製法および除草剤

Also Published As

Publication number Publication date
HU201751B (en) 1990-12-28
JPH01131175A (ja) 1989-05-24
DK631587A (da) 1988-06-03
FR2607502A1 (fr) 1988-06-03
TW203048B (fi) 1993-04-01
FR2607502B1 (fr) 1990-01-19
JPH064623B2 (ja) 1994-01-19
US5002945A (en) 1991-03-26
AU597446B2 (en) 1990-05-31
GR3006257T3 (fi) 1993-06-21
DK631587D0 (da) 1987-12-01
HU204812B (en) 1992-02-28
FI91754B (fi) 1994-04-29
FI91754C (fi) 1994-08-10
US5053417A (en) 1991-10-01
DE3782621T2 (de) 1993-04-22
CN87108111A (zh) 1988-09-28
ES2044901T3 (es) 1994-01-16
IL84554A (en) 1992-03-29
HU905023D0 (en) 1991-01-28
KR930004843B1 (ko) 1993-06-09
DE3782621D1 (de) 1992-12-17
EP0270091B1 (en) 1992-11-11
AU8181287A (en) 1988-06-02
US4996217A (en) 1991-02-26
EP0270091A1 (en) 1988-06-08
FI875102A0 (fi) 1987-11-18
IL84554A0 (en) 1988-04-29
HUT49128A (en) 1989-08-28
CN1020902C (zh) 1993-05-26
KR880007477A (ko) 1988-08-27

Similar Documents

Publication Publication Date Title
FI914603A7 (fi) Analogiamenetelmä lääkeaineena käyttökelpoisen pyridiinijohdannaisen valmistamiseksi
FI893100L (fi) Analogiamenetelmä asyylideoksiribonukleosidijohdannaisten valmistamiseksi
FI893467L (fi) Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
FI880163L (fi) Menetelmä lääkeaineena käytettävän liuoksen valmistamiseksi
FI871294L (fi) Menetelmä lääkeaineina käyttökelpoisten milbemysiinin johdannaisten valmistamiseksi
KR860005811A (ko) 티아졸리딘디온 유도체의 제조방법
FI882369A7 (fi) Menetelmä lääkeaineena käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI885917A7 (fi) Menetelmä heterosyklisten yhdisteiden valmistamiseksi
FI873467A7 (fi) Menetelmä 5-amino-4-hydroksivaleriaanahappojohdannaisten valmistamiseksi
FI885623A7 (fi) Menetelmä lääkeaineina käyttökelpoisten substituoitujen propaani-fosfiinihappoyhdisteiden valmistamiseksi
FI893520L (fi) Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi
FI874702A7 (fi) Menetelmä uusien bentsimidatsolijohdannaisten valmistamiseksi.
FI875229A0 (fi) Menetelmä uusien farmakologisesti aktiivisten katekolijohdoksien valmistamiseksi
FI864560L (fi) Menetelmä uusien insuliinijohdannaisten valmistamiseksi
BG49939A3 (bg) Метод за получаване на 2-анилино-пиримидинови производни
FI875102L (fi) Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
FI882590A7 (fi) Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
FI871022A7 (fi) Menetelmä lääkeaineina käyttökelpoisen difenyylimetaanijohdannaisen valmistamiseksi
FI874865L (fi) Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi
FI95036B (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
FI861655L (fi) Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi
PT87854A (pt) Process for the preparation of thio-urea derivatives
FI874789L (fi) Menetelmä valmistaa farmakologisesti aktiivisia substituoituja 1H-imidatsoleja

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: TANABE SEIYAKU CO., LTD.